Major Alzheimers Trial Shows New Drug Can Slow Disease Progression ScienceAlert

Results of an 18-month trial led by US pharmaceutical producer Eli Lilly have shown its new Alzheimer’s drug can delay the progression of the disease by up to 35.1 percent. That means across the tri… [+5020 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *